10.27
price up icon9.50%   0.80
 
loading
Schlusskurs vom Vortag:
$9.47
Offen:
$9.48
24-Stunden-Volumen:
200.14K
Relative Volume:
0.16
Marktkapitalisierung:
$554.44M
Einnahmen:
$2.80M
Nettoeinkommen (Verlust:
$-122.23M
KGV:
-4.4965
EPS:
-2.284
Netto-Cashflow:
$-46.53M
1W Leistung:
+23.74%
1M Leistung:
+31.26%
6M Leistung:
-39.92%
1J Leistung:
+51.60%
1-Tages-Spanne:
Value
$9.38
$10.43
1-Wochen-Bereich:
Value
$8.12
$10.40
52-Wochen-Spanne:
Value
$5.14
$33.68

Upstream Bio Inc Stock (UPB) Company Profile

Name
Firmenname
Upstream Bio Inc
Name
Telefon
781-208-2466
Name
Adresse
890 WINTER STREET, SUITE 200, WALTHAM
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2026-04-01
Name
Neueste SEC-Einreichungen
Name
UPB's Discussions on Twitter

Compare UPB vs VRTX, REGN, ALNY, ARGX, INSM

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
UPB icon
UPB
Upstream Bio Inc
10.26 511.75M 2.80M -122.23M -46.53M -2.284
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
453.17 115.58B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
756.85 79.23B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
330.68 43.59B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
694.36 43.26B 4.16B 1.29B 734.26M 19.58
INSM icon
INSM
Insmed Inc
148.91 31.97B 606.42M -1.28B -997.58M -6.403

Upstream Bio Inc Stock (UPB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-12-18 Eingeleitet Mizuho Outperform
2025-11-18 Eingeleitet Evercore ISI Outperform
2025-10-14 Eingeleitet Truist Buy
2024-11-05 Eingeleitet JP Morgan Overweight
2024-11-05 Eingeleitet Piper Sandler Overweight
2024-11-05 Eingeleitet TD Cowen Buy
2024-11-05 Eingeleitet William Blair Outperform
Alle ansehen

Upstream Bio Inc Aktie (UPB) Neueste Nachrichten

pulisher
07:28 AM

UPB: Verekitug demonstrated strong efficacy and safety in Phase 2, with Phase 3 trials set for 2027 - TradingView

07:28 AM
pulisher
07:26 AM

Upstream Bio plans Phase 3 trials for asthma drug in Q1 2027 - Investing.com

07:26 AM
pulisher
07:12 AM

Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

07:12 AM
pulisher
07:10 AM

Upstream Bio, Inc. unveils financial results and sets Phase 3 path for verekitug - Traders Union

07:10 AM
pulisher
07:05 AM

Upstream Bio (NASDAQ: UPB) deepens 2025 loss while推进 Phase 3 verekitug strategy - Stock Titan

07:05 AM
pulisher
07:00 AM

Upstream Bio plans two late-stage trials for asthma, nasal polyps in 2027 - Stock Titan

07:00 AM
pulisher
Mar 25, 2026

Upstream Bio (NASDAQ:UPB) Trading Up 11.2%What's Next? - MarketBeat

Mar 25, 2026
pulisher
Mar 25, 2026

Gainers Report: Is Upstream Bio Inc still a buy after recent gains2026 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 22, 2026

Upstream Bio, Inc.(NasdaqGS: UPB) dropped from S&P Biotechnology Select Industry Index - marketscreener.com

Mar 22, 2026
pulisher
Mar 22, 2026

Aug EndMonth: What is the next catalyst for Upstream Bio IncMarket Trend Report & Stock Timing and Entry Methods - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 20, 2026

Upstream Bio Inc expected to post a loss of 70 cents a shareEarnings Preview - TradingView

Mar 20, 2026
pulisher
Mar 20, 2026

UPB Stock Price, Quote & Chart | UPSTREAM BIO INC (NASDAQ:UPB) - ChartMill

Mar 20, 2026
pulisher
Mar 18, 2026

UPB | Upstream Bio, Inc. Common Insider Trading - Quiver Quantitative

Mar 18, 2026
pulisher
Mar 18, 2026

Upstream Bio CFO Gray sells $7915 in shares - Investing.com

Mar 18, 2026
pulisher
Mar 18, 2026

Upstream Bio CFO Gray sells $7915 in shares By Investing.com - Investing.com South Africa

Mar 18, 2026
pulisher
Mar 17, 2026

Upstream Bio CEO Makes Notable Move With Fresh Stock Sale - TipRanks

Mar 17, 2026
pulisher
Mar 17, 2026

Upstream Bio (UPB) CFO executes automatic share sale to cover RSU taxes - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Upstream Bio (UPB) CMO auto-sells 894 shares to cover RSU taxes - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Tax-related sale: Upstream Bio (UPB) CEO automatically sells 2,093 shares - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Tax-withholding share sale by Upstream Bio (UPB) General Counsel disclosed - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Tax-related stock sale by Upstream Bio (UPB) chief business officer - Stock Titan

Mar 17, 2026
pulisher
Mar 14, 2026

Risk Recap: Whats next for Upstream Bio Inc stockM&A Rumor & Short-Term Swing Trade Alerts - baoquankhu1.vn

Mar 14, 2026
pulisher
Mar 14, 2026

Integral Health Asset Management LLC Acquires New Stake in Upstream Bio, Inc. $UPB - MarketBeat

Mar 14, 2026
pulisher
Mar 13, 2026

Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB), TScan Therapeutics (TCRX) and Teladoc (TDOC) - The Globe and Mail

Mar 13, 2026
pulisher
Mar 11, 2026

Upstream Bio (NASDAQ:UPB) Trading 14.4% HigherShould You Buy? - MarketBeat

Mar 11, 2026
pulisher
Mar 09, 2026

UPB: Phase II data support quarterly dosing for verekitug, with phase III and COPD programs advancing - TradingView

Mar 09, 2026
pulisher
Mar 09, 2026

UPB: Verekitug's quarterly dosing shows robust efficacy, with phase 3 and COPD programs advancing - TradingView

Mar 09, 2026
pulisher
Mar 09, 2026

Upstream Bio, Inc. CEO joins Leerink Partners fireside chat at global healthcare conference - Traders Union

Mar 09, 2026
pulisher
Mar 06, 2026

Dip Buying: Is Upstream Bio Inc forming a breakout pattern2025 Stock Rankings & Fast Entry High Yield Stock Tips - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Upstream Bio's selloff may be 'overdone,' but analyst highlights asthma drug's competitive edge concerns - MSN

Mar 06, 2026
pulisher
Mar 06, 2026

Aug Sectors: Can Upstream Bio Inc deliver consistent dividendsJuly 2025 Outlook & Community Verified Watchlist Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Lifesci Capital Forecasts Upstream Bio Q2 Earnings - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Brokerages Set Upstream Bio, Inc. (NASDAQ:UPB) Price Target at $45.25 - Defense World

Mar 06, 2026
pulisher
Mar 05, 2026

Why Did UPB Stock Plunge 40% Today? - Stocktwits

Mar 05, 2026
pulisher
Mar 04, 2026

RSI Check: Can Upstream Bio Inc outperform in the next rallyWeekly Trade Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

UPB: Verekitug shows best-in-class efficacy and safety, advancing to phase 3 with quarterly dosing - TradingView

Mar 04, 2026
pulisher
Mar 04, 2026

CEO Rand Sutherland hosts live conference fireside chat, Upstream Bio, Inc. asserts - Traders Union

Mar 04, 2026
pulisher
Mar 04, 2026

Upstream Bio (UPB) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

Upstream Bio, Inc. (NASDAQ:UPB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 03, 2026
pulisher
Mar 01, 2026

Upstream Bio presents additional Phase 2 data for verekitug - Investing.com South Africa

Mar 01, 2026
pulisher
Mar 01, 2026

Upstream Bio presents additional Phase 2 data for verekitug By Investing.com - Investing.com Canada

Mar 01, 2026
pulisher
Mar 01, 2026

Upstream Bio, Inc. unveils new analyses from VIBRANT Phase 2 trial at AAAAI2026 - Traders Union

Mar 01, 2026
pulisher
Mar 01, 2026

Upstream Bio says primary endpoint showed reduction of -1.95 in nasal polyp score - marketscreener.com

Mar 01, 2026
pulisher
Mar 01, 2026

Upstream Bio Says Primary Endpoint Showed Reduction of -1.95 in Nasal Polyp Score - TradingView

Mar 01, 2026
pulisher
Mar 01, 2026

Upstream Bio Presents Additional Analyses from the Phase 2 - GlobeNewswire

Mar 01, 2026
pulisher
Feb 28, 2026

UPB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 28, 2026
pulisher
Feb 27, 2026

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 505% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 27, 2026
pulisher
Feb 26, 2026

Upstream Bio to present verekitug CRSwNP trial data at AAAAI By Investing.com - Investing.com Australia

Feb 26, 2026
pulisher
Feb 26, 2026

Upstream Bio to present verekitug CRSwNP trial data at AAAAI - Investing.com

Feb 26, 2026
pulisher
Feb 26, 2026

Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026 - Bitget

Feb 26, 2026
pulisher
Feb 25, 2026

UPB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 25, 2026

Finanzdaten der Upstream Bio Inc-Aktie (UPB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Upstream Bio Inc-Aktie (UPB) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Deykin Aaron
Chief Medical Officer
Mar 16 '26
Sale
9.29
894
8,305
32,687
Sutherland Everett Rand
Chief Executive Officer
Mar 16 '26
Sale
9.29
2,093
19,444
72,907
Ambrose Allison
General Counsel
Mar 16 '26
Sale
9.29
475
4,413
16,525
Houghton Adam
Chief Business Officer
Mar 16 '26
Sale
9.29
699
6,494
24,301
$26.98
price down icon 0.99%
$47.05
price up icon 3.03%
$52.97
price up icon 3.11%
$88.06
price down icon 0.83%
ONC ONC
$272.99
price down icon 1.11%
$146.63
price up icon 6.51%
Kapitalisierung:     |  Volumen (24h):